Randal Dillinger: Letter to my congressman
Randal Dillinger, Director of Business Development and Communications at Hoosier Cancer Research Network, shared a post on X:
“Letter to my congressman:
This week, I have been attending GI25, a scientific conference, The American Society of Clinical Oncology’s annual meeting focused on research advancements in GI cancers (pancreatic, colorectal, gastric, biliary tract and others).
I am here to support the work of the researchers whose clinical trials my company manages, and to help generate new opportunities for collaboration.
In the midst of this conference, during a break between meetings, I read the headlines that the new administration had cancelled all NCI and NIH section meetings, communications, scientific publication, hirings, and other activities.
There are thousands of cancer researchers who collaborate with their federal peers, and whose work relies on the resources provided by these agencies. All of their vital activity under the NIH umbrella came to an immediate halt in real time during this conference.
This is not hyperbole, and while I wish this were simply the plot for a fictional thriller, it is our present reality. Every day this persists is a day of progress lost, and consequently a longer path toward badly needed advancements in research.
Our friends, neighbors, and family members who battle chronic or deadly disease deserve better.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023